About Inventia Life Science
Inventia Life Science is a Healthcare company based in Sydney (Australia) founded in 2013 by Cameron Ferris, Julio Ribeiro, and Aidan O'Mahony. Developer of 3D bio-printers. It operates in the Healthcare and Technology sectors. Inventia Life Science has raised $41 million across 5 funding rounds from investors including Superfund, Blackbird Ventures and Skip Capital. Its chief executive, as recorded, is Julio Ribeiro. Inventia Life Science offers products and services including RASTRUM™ Allegro, RASTRUM™ Cloud, and RASTRUM™ Matrices. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Instruments and 3D Bioprinting.
Company details
Inventia Life Science was founded in 2013 in Sydney, Australia, within the biotechnology sector. 3D bio-printers are developed by the company for applications in biomedical research and drug discovery. Human cells are printed using a platform that incorporates natural and synthetic hydrogel bio-inks. This technology supports 3D cell biology studies, including cancer drug testing, through digital bio-printing methods. Operations focus on advancing research tools for scientific and pharmaceutical uses.
- Headquarters Sydney, Australia
- Founders Cameron Ferris, Julio Ribeiro, Aidan O'Mahony
- SectorsHealthcareTechnology
- Email••••••••
- Phone•••• ••••
- Website inventia.life
- Social LinkedIn X Facebook YouTube
- Total Equity Funding$41M (USD)
in 5 rounds
- Latest Funding Round$4.4M (USD), Series B
Jun 2022
- InvestorsSuperfund
& 5 more
Products & Services of Inventia Life Science
Inventia Life Science offers a comprehensive portfolio of products and services, including RASTRUM™ Allegro, RASTRUM™ Cloud, and RASTRUM™ Matrices.
Enables rapid production of scalable 3D cell models for research.
Provides architectures for managing and analyzing cell models online.
Offers tunable environments for 3D cell culture applications.
Apps and channels of Inventia Life Science
its YouTube channel Inventia Life Science has 84 subscribers and 8 videos.
Videos from Inventia Life Science
The most watched videos on Inventia Life Science's YouTube channel, Inventia Life Science (84 subscribers). Click a video to play it here.
More on Inventia Life Science.
Funding Insights of Inventia Life Science
Inventia Life Science has successfully raised a total of $41M across 5 strategic funding rounds. The most recent funding activity was a Series B round of $4.4 million completed in June 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $41M
- Total Rounds 5
- Last Round Series B — $4.4M
- First Round $1.6M
(Jun 2017)
- Investors Count 6
All 5 funding rounds of Inventia Life Science with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2022 | $4.4M | Series B | – | – | |
| Dec 2021 | $25M | Series B | – | Blackbird Ventures | |
| Dec 2019 | $10M | Series A | – | – | |
| Oct 2018 | Seed | – | – | ||
| Jun 2017 | $1.6M | Seed | – | – |
6 investors in total: 6 institutional.
Investors in Inventia Life Science
Inventia Life Science has secured backing from 6 investors, including institutional and venture fund investors. Prominent investors backing the company include Superfund, Blackbird Ventures and Skip Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Investments are made in seed, early, and later-stage tech companies. | blackbird.vc | Surry Hills, Australia | ||
Tech-focused VC firm primarily investing in early to late-stage startups | skipcapital.com | Sydney, Australia | ||
Investments are directed toward early-stage tech startups by AirTree. | airtree.vc | Surry Hills, Australia | ||
Venture capital investments are made in deep tech founders. | mseq.vc | Eveleigh, Australia | ||
Prisma Capital is recognized as an independent alternative investment manager. | 2017 | prismacapital.com.br | ||
Investment solutions are offered by Superfund for global markets. | superfund.com |
Investor details for Inventia Life Science
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Inventia Life Science
22 people are tracked at Inventia Life Science (10 in leadership, 12 in team).
| Name | Role | Group |
|---|---|---|
Cameron Ferris | Co-Founder & COO | Leadership |
Julio Ribeiro | Co-Founder & CEO | Leadership |
Aidan O'Mahony | Co-Founder & CTO | Leadership |
Kai Liu | Head Of Manufacturing & Operations | Leadership |
Susan Harrison Uy | Vice President, Commercial | Leadership |
Dr Julio Ribeiro In Medicine | Founder/chief Executive Officer | Leadership |
Dana Foreman | Director, Integrated Marketing | Leadership |
Darren Bailey | Head Of Finance | Leadership |
Bob Groneman | Chief Product Officer | Leadership |
Jason Leavens | Head Of Product - Ligo | Leadership |
Hannah Roddy | North America- Academic Account Manager | Team |
Joanna M. Wasielewska | Senior Scientist And Program Manager | Team |
Ali McCorkindale | Principal Scientist | Team |
Christine Yee | Research Scientist | Team |
Zack Artist | Lead Biomedical Engineer | Ligō Technical Lead | Team |
Anton Lohr | Senior Software Engineer | Team |
Joseph Calder | Field Service Engineer Uk/eu | Team |
Tien Nguyen | Team Leader - Field Service Engineering | Team |
Thomas Grundy | Senior Product Specialist & Technical Sales | Team |
Whitney Symons | Customer Success Manager | Team |
2 more people are available in the full profile.
Complete people profiles for Inventia Life Science
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Inventia Life Science
3 dated milestones of Inventia Life Science across 9 years, from founding to its latest funding, stage changes and deals.
- Founded Inventia Life Science is founded.
- Funding First funding round of $1.6M.
- Funding Latest funding round, Series B, of $4.4M.
Web traffic of Inventia Life Science
Websites that share an audience with Inventia Life Science (inventia.life).
Websites whose visitors overlap most with Inventia Life Science. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| automata.tech | 100% | 37.7K | #828,371 | View details |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Inventia Life Science
Complete news archive for Inventia Life Science
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Inventia Life Science
Inventia Life Science was founded in 2013 and raised its 1st funding round 4 years after it was founded.
Inventia Life Science is headquartered in Sydney, Australia. It is registered at Sydney, New South Wales, Australia.
Julio Ribeiro is the CEO of Inventia Life Science, as recorded in our data. They have also founded this company.
Inventia Life Science is a funded company, having raised a total of $41M across 5 funding rounds to date. The company's 1st funding round was a Seed of $1.6M, raised on Jun 2017.
Inventia Life Science was founded in 2013 in Sydney, Australia, within the biotechnology sector. 3D bio-printers are developed by the company for applications in biomedical research and drug discovery. Human cells are printed using a platform that incorporates natural and synthetic hydrogel bio-inks. This technology supports 3D cell biology studies, including cancer drug testing, through digital bio-printing methods. Operations focus on advancing research tools for scientific and pharmaceutical uses.
Inventia Life Science offers RASTRUM™ Allegro, RASTRUM™ Cloud, and RASTRUM™ Matrices.
Inventia Life Science has 6 investors. Key investors include Superfund, Blackbird Ventures, Skip Capital, AirTree, and Main Sequence.